Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
WOPD requirement under ACA Section 6407 Under ACA Section 6407, a written order prior to delivery (WOPD) is required for HCPCS Code E0784
Background on Mounjaro (Tirzepatide) Mounjaro is a dual GIP and GLP-1 receptor agonist used for the treatment of Type 2 diabetes and is under investigation/used off-label for weight management
Research-grade retatrutide is synthesized by third-party labs for laboratory use, with quality depending entirely on the vendor's sourcing and testing practices
Some lean mass reduction is a normal part of any significant weight loss, around 25 percent of total weight lost in clinical trials
In rodent models of diabetic or pressure-overload cardiomyopathy, dulaglutide reduced myocardial collagen content by approximately 35% and improved diastolic function [48]
